By Gårdmark M.   Brynne L.   Hammarlund-Udenaes M.   Karlsson M.O.   in Clinical Pharmacokinetics

ISSN:0312-5963|36|2|145-167

Adis International‎(1999)‎

Access to resources Favorite 2.1090345

By Sundberg J.   Jonsson S.   Karlsson M.O.   Oskarsson A.   in Toxicology and Applied Pharmacology

ISSN:0041-008X|154|2|160-169

Elsevier‎(1999)‎

Access to resources Favorite 2.1090345

By Henningsson A.   Sparreboom A.   Sandstrom M.   Freijs A.   Larsson R.   Bergh J.   Nygren P.   Karlsson M.O.   in European Journal of Cancer

ISSN:0959-8049|39|8|1105-1114

Elsevier‎(2003)‎

Access to resources Favorite 1.6872276

By Abelo A.   Gabrielsson J.   Holstein B.   Eriksson U.G.   Holmberg J.   Karlsson M.O.   in European Journal of Pharmaceutical Sciences

ISSN:0928-0987|14|4|339-346

Elsevier‎(2001)‎

Access to resources Favorite 1.6872276

By Kloft C.   Graefe E-U.   Tanswell P.   Scott A. M.   Hofheinz R.   Amelsberg A.   Karlsson M. O.   in Investigational New Drugs

ISSN:0167-6997|22|1|39-52

Springer Publishing Company ‎(2004)‎

Access to resources Favorite 1.6872276

By Sundberg J.   Jonsson S.   Karlsson M.O.   Hallen I.P.   Oskarsson A.   in Toxicology and Applied Pharmacology

ISSN:0041-008X|151|2|319-329

Elsevier‎(1998)‎

Access to resources Favorite 1.6872276

By Aarons L.   Karlsson M.O.   Mentre F.   Rombout F.   Steimer J.-L.   van Peer A.   invited COST B15 Experts   in European Journal of Pharmaceutical Sciences

ISSN:0928-0987|13|2|115-122

Elsevier‎(2001)‎

Access to resources Favorite 1.4763242

By Trouw R.A.J.   De Wit M.J.   Olsson Gisleskog P.   Hermann D.   Hammarlund-Udenaes M.   Karlsson M.O.   in European Journal of Pharmaceutical Sciences

ISSN:0928-0987|8|4|291-299

Elsevier‎(1999)‎

Access to resources Favorite 1.4763242